Focal Neuropathy

Neuropathies are characterized by damage to the nerves. There are four types of neuropathy; peripheral, proximal, focal, and autonomic. Focal neuropathy, also called mononeuropathy, occurs when there is damage to a single nerve.

Treatment at the Stem Cells Transplant Institute could help improve the symptoms of focal neuropathies including:

  • Severe pain in a specific area, such as the lower back
  • Chest or abdominal pain
  • Eye pain
  • Double vision
  • Paralysis on one side of the face
  • Difficulty focusing your eyes
  • Pain numbness and tingling such as what is experienced with carpal tunnel syndrome
  • Weakness

What is focal neuropathy?

Also called mononeuropathy, focal neuropathy affects a single nerve and usually appears abruptly. The most common areas of focal neuropathy are the brain, torso, hand, shoulder, leg or feet. The damaged nerve can cause weakness, pain, numbness or paralysis.The type of neuropathy is less common than autonomic or peripheral neuropathy.The most common cause of focal neuropathy is diabetes.Cranial neuropathy is a type of focal neuropathy.

What causes focal neuropathy?

The most common cause of focal neuropathy is diabetes. Overtime, high blood sugar and high levels of fats in the blood damage the nerves and the small blood vessels that carry nutrients to the nerves.

How can stem cell therapy improve the symptoms of focal neuropathy?

Mesenchymal stem cells produce:

  1. Proteins that support the growth and survival of neurons
  2. Angiogenic factors that are essential for the healing, growth, development, and maintenance of blood vessels
  3. Immunomodulatory substances that can reverse the damage to the nerves

What are the advantages of human umbilical cord mesenchymal stem cells?

  • Abundant supply containing up to 10 times more stem cells than bone marrow or adipose derived stem cells
  • hUC-MSC have immunosuppressors and immunomodulatory properties that allow their use in any individual without rejection- Human Leukocyte Antigen (HLA) matching is not necessary
  • Greater proliferation ability than adult autologous stem cells
  • They regenerate at a very rapid rate
  • They are young and very adaptive
  • They have not been impacted by the aging process
  • They have not been affected by environmental toxins
  • Umbilical cord stem cells can be administered multiple times over the course of days
  • Eliminates the need to collect stem cells from the patient’s fat or hip bone reducing pain and recovery time

How are the stem cells collected?

We use only umbilical cord stem cells that are derived exclusively from umbilical cord donations. 

The umbilical cord stem cells from are collected after informed consent has been given by the parent, or parents, and only after the delivery of the baby.

The collection follows strict ethical protocols ensuring the stem cells are from safe, reliable sources using a non-invasive, simple and painless procedure. Once collected, the cord blood is then screened for disease.

How are the stem cells administered?

Depending on the nerve affected, the stem cells may be administered by intravenously, intrathecally or directly into the site of damage.

About the Stem Cells Transplant Institute

Costa Rica has one of the best healthcare systems in world and is ranked among the highest for medical tourism.

Using the most advanced technologies, the team of experts at The Stem Cells Transplant Institute believes in the potential of stem cell therapy for the treatment of neuropathy.

We are committed to providing personalized service and the highest quality of care to every patient.

Contact the experts at the Stem Cells Transplant Institute to see if stem cell treatment might help you.

Scientific References:

  1. Cell Death Discovery (2016) 2, e16055; doi:10.1038/cddiscovery.2016.55; published online 11 July 2016 Mesenchymal stem cells to treat diabetic neuropathy: a long and strenuous way from bench to the clinic JY Zhou
  2. Han, JW et al., Bone Marrow-Derived Mesenchymal Stem Cells Improve Diabetic Neuropathy by Direct Modulation of Both Angiogenesis and Myelination in Peripheral Nerves. Cell transplant. 2016;25(2):313-26. doi: 10.3727/096368915X688209. Epub 2015 May 13